You are an executive with a major pharmaceutical company. Your company is ready to release a cure-all for the common cold. However, the drug has some terrible side effects for a very few of its users, including potential permanent paralysis and/or death. How should you advise your company about deciding whether to sell the product or not? How does the standard, or approach, of ethics that is applied affect this answer? In other words, you answer needs to include